Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) EBT Margin: 2020-2022

  • SELLAS Life Sciences Group's EBT Margin fell 163411.00% to -1,673.50% in Q1 2022 from the same period last year, while for Mar 2022 it was -378.90%, marking a year-over-year change of. This contributed to the annual value of -4,130.10% for FY2022, which is 385463.00% down from last year.
  • SELLAS Life Sciences Group's EBT Margin amounted to -1,673.50% in Q1 2022, which was down 614.05% from -234.37% recorded in Q2 2021.
  • In the past 5 years, SELLAS Life Sciences Group's EBT Margin ranged from a high of -39.39% in Q1 2021 and a low of -1,673.50% during Q1 2022.
  • Its 3-year average for EBT Margin is -541.54%, with a median of -226.63% in 2021.
  • Data for SELLAS Life Sciences Group's EBT Margin shows a maximum YoY tumbled of 163,411bps (in 2022) over the last 5 years.
  • Over the past 3 years, SELLAS Life Sciences Group's EBT Margin (Quarterly) stood at -218.89% in 2020, then reached -234.37% in 2021, then crashed by 163,411bps to -1,673.50% in 2022.
  • Its EBT Margin stands at -1,673.50% for Q1 2022, versus -234.37% for Q2 2021 and -39.39% for Q1 2021.